Aeruginosin LH606
| Internal ID | 58b698c0-02a7-4c99-bbcf-da2105d68fdc |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Dipeptides |
| IUPAC Name | (2S,3aS,6R,7aS)-N-(1-carbamimidoylpyrrolidin-2-yl)-1-[(2R)-2-[[(2R)-3-(3-chloro-4-hydroxyphenyl)-2-hydroxypropanoyl]amino]-4-methylpentanoyl]-6-hydroxy-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxamide |
| SMILES (Canonical) | CC(C)CC(C(=O)N1C2CC(CCC2CC1C(=O)NC3CCCN3C(=N)N)O)NC(=O)C(CC4=CC(=C(C=C4)O)Cl)O |
| SMILES (Isomeric) | CC(C)C[C@H](C(=O)N1[C@H]2C[C@@H](CC[C@H]2C[C@H]1C(=O)NC3CCCN3C(=N)N)O)NC(=O)[C@@H](CC4=CC(=C(C=C4)O)Cl)O |
| InChI | InChI=1S/C29H43ClN6O6/c1-15(2)10-20(33-27(41)24(39)12-16-5-8-23(38)19(30)11-16)28(42)36-21-14-18(37)7-6-17(21)13-22(36)26(40)34-25-4-3-9-35(25)29(31)32/h5,8,11,15,17-18,20-22,24-25,37-39H,3-4,6-7,9-10,12-14H2,1-2H3,(H3,31,32)(H,33,41)(H,34,40)/t17-,18+,20+,21-,22-,24+,25?/m0/s1 |
| InChI Key | VTKSRNODZPGCEU-ZNLUQXHSSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C29H43ClN6O6 |
| Molecular Weight | 607.10 g/mol |
| Exact Mass | 606.2932608 g/mol |
| Topological Polar Surface Area (TPSA) | 192.00 Ų |
| XlogP | 2.10 |
| Atomic LogP (AlogP) | 1.04 |
| H-Bond Acceptor | 7 |
| H-Bond Donor | 7 |
| Rotatable Bonds | 9 |
| DTXSID401047809 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9633 | 96.33% |
| Caco-2 | - | 0.8763 | 87.63% |
| Blood Brain Barrier | - | 0.6500 | 65.00% |
| Human oral bioavailability | - | 0.7571 | 75.71% |
| Subcellular localzation | Mitochondria | 0.4640 | 46.40% |
| OATP2B1 inhibitior | - | 0.8543 | 85.43% |
| OATP1B1 inhibitior | + | 0.8504 | 85.04% |
| OATP1B3 inhibitior | + | 0.9352 | 93.52% |
| MATE1 inhibitior | - | 0.8200 | 82.00% |
| OCT2 inhibitior | - | 0.6000 | 60.00% |
| BSEP inhibitior | + | 0.8551 | 85.51% |
| P-glycoprotein inhibitior | + | 0.6558 | 65.58% |
| P-glycoprotein substrate | + | 0.8595 | 85.95% |
| CYP3A4 substrate | + | 0.7267 | 72.67% |
| CYP2C9 substrate | - | 0.6150 | 61.50% |
| CYP2D6 substrate | - | 0.7656 | 76.56% |
| CYP3A4 inhibition | - | 0.8098 | 80.98% |
| CYP2C9 inhibition | - | 0.7402 | 74.02% |
| CYP2C19 inhibition | - | 0.6580 | 65.80% |
| CYP2D6 inhibition | - | 0.8510 | 85.10% |
| CYP1A2 inhibition | - | 0.7829 | 78.29% |
| CYP2C8 inhibition | + | 0.5654 | 56.54% |
| CYP inhibitory promiscuity | - | 0.8612 | 86.12% |
| UGT catelyzed | - | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.5912 | 59.12% |
| Eye corrosion | - | 0.9838 | 98.38% |
| Eye irritation | - | 0.9448 | 94.48% |
| Skin irritation | - | 0.7602 | 76.02% |
| Skin corrosion | - | 0.9227 | 92.27% |
| Ames mutagenesis | - | 0.7200 | 72.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.5674 | 56.74% |
| Micronuclear | + | 0.9100 | 91.00% |
| Hepatotoxicity | + | 0.5125 | 51.25% |
| skin sensitisation | - | 0.8325 | 83.25% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.9889 | 98.89% |
| Mitochondrial toxicity | + | 1.0000 | 100.00% |
| Nephrotoxicity | - | 0.8815 | 88.15% |
| Acute Oral Toxicity (c) | III | 0.6104 | 61.04% |
| Estrogen receptor binding | + | 0.8007 | 80.07% |
| Androgen receptor binding | + | 0.7208 | 72.08% |
| Thyroid receptor binding | + | 0.5222 | 52.22% |
| Glucocorticoid receptor binding | + | 0.7027 | 70.27% |
| Aromatase binding | + | 0.6191 | 61.91% |
| PPAR gamma | + | 0.7514 | 75.14% |
| Honey bee toxicity | - | 0.7590 | 75.90% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | - | 0.5705 | 57.05% |
| Fish aquatic toxicity | + | 0.9440 | 94.40% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.46% | 98.95% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 99.46% | 90.17% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.63% | 96.09% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.95% | 91.11% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.79% | 94.45% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.07% | 98.33% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 96.49% | 90.71% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 95.59% | 90.00% |
| CHEMBL3837 | P07711 | Cathepsin L | 94.54% | 96.61% |
| CHEMBL204 | P00734 | Thrombin | 93.59% | 96.01% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 93.36% | 91.19% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.23% | 95.89% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 92.79% | 93.56% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 92.22% | 100.00% |
| CHEMBL4835 | P00338 | L-lactate dehydrogenase A chain | 91.96% | 95.34% |
| CHEMBL238 | Q01959 | Dopamine transporter | 91.84% | 95.88% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.38% | 97.09% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.21% | 95.56% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 90.97% | 96.03% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 90.53% | 100.00% |
| CHEMBL4235 | P28845 | 11-beta-hydroxysteroid dehydrogenase 1 | 89.42% | 97.98% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 89.42% | 97.14% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 88.95% | 99.15% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 88.70% | 98.10% |
| CHEMBL5028 | O14672 | ADAM10 | 88.25% | 97.50% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 87.79% | 92.29% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 86.97% | 100.00% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 86.66% | 91.03% |
| CHEMBL3691 | Q13822 | Autotaxin | 86.10% | 96.39% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 85.48% | 89.62% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 85.47% | 96.47% |
| CHEMBL3492 | P49721 | Proteasome Macropain subunit | 85.39% | 90.24% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 85.35% | 96.21% |
| CHEMBL205 | P00918 | Carbonic anhydrase II | 85.24% | 98.44% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 84.43% | 97.50% |
| CHEMBL236 | P41143 | Delta opioid receptor | 84.40% | 99.35% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 84.10% | 90.08% |
| CHEMBL1978 | P11511 | Cytochrome P450 19A1 | 83.66% | 91.76% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 83.63% | 96.67% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.57% | 96.90% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 83.52% | 80.71% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 83.26% | 97.64% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 83.09% | 95.50% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 81.97% | 85.00% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 81.76% | 85.11% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 81.63% | 90.24% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 81.11% | 90.65% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 80.14% | 96.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 101884819 |
| LOTUS | LTS0097466 |
| wikiData | Q105292809 |